Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:address |
18 East 16th Street, Suite 307, New York, NY 10003, USA
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
development of novel therapies for infectious diseases
|
| gptkbp:fullName |
gptkb:Artemis_Therapeutics_Inc.
|
| https://www.w3.org/2000/01/rdf-schema#label |
ARTM
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Artemisone
|
| gptkbp:status |
publicly traded
|
| gptkbp:stockSymbol |
gptkb:ARTM
|
| gptkbp:website |
http://www.artemis-therapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Exo_commuter_rail
gptkb:REM_(Réseau_express_métropolitain) gptkb:Saint-Jérôme_line gptkb:STM_(Montreal) gptkb:RTL_(Réseau_de_transport_de_Longueuil) gptkb:Société_de_transport_de_Montréal gptkb:Autorité_régionale_de_transport_métropolitain gptkb:Exo_commuter_trains |
| gptkbp:bfsLayer |
7
|